|
|
|
|
LEADER |
02225cam a2200445 4500 |
001 |
PPN02832076X |
005 |
20031219080000.0 |
009 |
DYNIX_BUNAN_495233 |
010 |
|
|
|a 0-521-47321-7
|b hb
|
020 |
|
|
|a US
|b 976482
|
035 |
|
|
|a ocm36470679
|
100 |
|
|
|a 19970224d1998 u u fre 0103
|
101 |
0 |
|
|a eng
|
102 |
|
|
|a GB
|b en
|
105 |
|
|
|a a # 000|y
|
200 |
0 |
|
|a Drug resistance in the treatment of cancer
|f edited by Herbert M. Pinedo and Giuseppe Giaccone
|
210 |
|
|
|a Cambridge, U.K.
|a New York
|c Cambridge University Press
|d c1998
|
215 |
|
|
|a xvi, 323 p.
|c ill.
|d 24 cm
|
225 |
2 |
|
|a Cancer, clinical science in practice
|
327 |
1 |
|
|a Resistance mechanisms to antimetabolites
|a Resistance to antitumor alkylating agents and cisplatin
|a The MDR genes
|a Topoisomerase genes and resistance to topoisomerase inhibitors
|a Genes that modulate apoptosis: major determinatns of drug resistance
|a Clinical implications of drug resistance
|a The reversal of multidrug resistance
|a Effect of dose and schedule on chemotherapeutic drug resistance
|a Circumvention of drug resistance by high-dose chemotherapy in solid tumors
|a Enhancing drug effectiveness by gene transfer
|
410 |
|
|
|t Cancer, clinical science in practice
|
606 |
1 |
|
|3 PPN027567931
|a Cellules cancéreuses
|3 031363695
|x Résistance aux médicaments
|2 rameau
|
610 |
1 |
|
|3 PPN040835316
|a RESISTANCE MEDICAMENT ANTINEOPLASIQUE
|3 040760200
|x PHYSIOLOGIE
|2 fmesh
|
610 |
1 |
|
|3 PPN040664007
|a ANTINEOPLASIQUES
|3 038961784
|x USAGE THERAPEUTIQUE
|2 fmesh
|
610 |
2 |
|
|a Antineoplastic Agents
|x therapeutic use
|2 mesh
|
610 |
1 |
|
|a Drug Resistance, Neoplasm
|x physiology
|2 mesh
|
610 |
1 |
|
|a Drug resistance in cancer cells
|2 lc
|
676 |
|
|
|a 616.99/4061
|v 21
|
680 |
|
|
|a RC271.C5
|b D7778 1998
|
686 |
|
|
|a QV 269
|b D7945 1998
|2 usnlm
|
686 |
|
|
|a 1998 E-053
|2 usnlm
|
702 |
|
1 |
|a Giaccone
|b Giuseppe
|
702 |
|
1 |
|a Pinedo
|b H. M.
|
801 |
|
2 |
|a FR
|b AUROC
|c 20001227
|g AFNOR
|
801 |
|
1 |
|a US
|b OCLC
|c 20001227
|g AACR2
|
801 |
|
3 |
|a FR
|b Abes
|c 20001227
|g AFNOR
|
930 |
|
|
|5 441092101:166871214
|b 441092101
|l 495233
|a QZ 266 PIN
|j b
|
979 |
|
|
|a SAN
|
993 |
|
|
|a 0557639883
|b SAN
|c QZ 266 PIN
|d LETAG
|e SANT2
|f I
|g 28-06-2002
|h 24-10-2002
|k 130.00
|o 14-12-2002
|p 1
|s 63988
|t LETAG
|u SANT2
|v i
|
998 |
|
|
|a 65054
|